BioPharma CreditLSE:BPCR +0.63%49 OCF Yield % is 8.44 as of Jul. 02, 2026, which is 10% below its 10-year median of 9.43. GuruFocus rates LSE:BPCR with a GF Score™ of 49/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,510 Asset Management companies, BioPharma Credit ranks better than 71.19% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
BioPharma Credit OCF Yield % Related Terms
BioPharma Credit OCF Yield % Historical Data
* Premium members only.
The historical data trend for BioPharma Credit's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, BioPharma Credit's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioPharma Credit OCF Yield % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, BioPharma Credit's OCF Yield % distribution charts can be found below:
* The bar in red indicates where BioPharma Credit's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioPharma Credit (LSE:BPCR) has a OCF Yield % of 8.44 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BioPharma Credit and its competitors. This is 10% below median its historical median of 9.43. Over the past decade, BioPharma Credit's OCF Yield % has ranged from 4.23 to 16.56. According to the industry distribution chart, BioPharma Credit ranks #435 out of 1510 companies in the Asset Management industry, placing it in the top 28.8%.
Is BioPharma Credit's OCF Yield % too high?
BioPharma Credit's current OCF Yield % of 8.44 is 10% below median its 10-year median of 9.43. Over the past 10 years, this metric has ranged from a low of 4.23 to a high of 16.56. The Asset Management industry median OCF Yield % is 2.74. BioPharma Credit's value of 8.44 is 208% above this industry median. Based on the distribution chart, BioPharma Credit ranks #435 out of 1510 companies in the Asset Management industry, which is above the industry midpoint. Overall, BioPharma Credit has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioPharma Credit's OCF Yield % compare to BLK and BX?
According to the Asset Management industry distribution chart, BioPharma Credit ranks #435 out of 1510 companies for OCF Yield %. This puts BioPharma Credit in the upper half of its industry. The industry median OCF Yield % is 2.74. BioPharma Credit's value of 8.44 is 208% above this benchmark. Historically, BioPharma Credit's own OCF Yield % has ranged from 4.23 to 16.56 over the past decade. While the company's 10-year median is 9.43 vs. the industry median of 2.74, BioPharma Credit has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for an Asset Management company?
The median OCF Yield % among Asset Management companies is 2.74, based on 1,510 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioPharma Credit's current OCF Yield % of 8.44 is 208% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BioPharma Credit and its competitors. For the Asset Management industry, the median OCF Yield % is 2.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioPharma Credit's current OCF Yield % is 8.44, which is 10% below median its own 10-year median of 9.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioPharma Credit stock overvalued right now?
Based on GuruFocus' analysis, BioPharma Credit (LSE:BPCR) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.96 — trading 1% below its estimated fair value. The current OCF Yield % is 8.44, which is 10% below median its 10-year median of 9.43 and 208% above the Asset Management industry median of 2.74. BioPharma Credit's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For BioPharma Credit (LSE:BPCR), the current OCF Yield % is 8.44 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioPharma Credit (LSE:BPCR) Overvalued in 2026?
Based on GuruFocus' analysis, BioPharma Credit stock appears to be undervalued.
The current stock price of $0.96 is trading 1% below its estimated GF Value™ of $0.97.
GuruFocus considers BioPharma Credit to be Fairly Valued.
Key valuation signals for LSE:BPCR:
OCF Yield %: 8.44 (10% below median its 10-year median of 9.43)
GF Value™: $0.97 vs. price of $0.96 (1% below fair value)
Industry Position: 208% above the Asset Management median (#435 of 1510)
No single metric tells the full story. See the LSE:BPCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioPharma Credit PLC is an investment trust. Its investment objective is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The trust focuses on achieving its investment objective through direct or indirect exposure to debt assets, which include royalty investments, senior secured debt, unsecured debt, and credit linked notes. Its diversified investment portfolio is mainly secured by approved life sciences products and the cash flows derived from their sales.
49GF Score
Get the complete analysis for LSE:BPCR
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BPCR has been successfully added to your 
